Application of quantum dots as vectors in targeted survivin gene siRNA delivery

Jianjiang Zhao1, Xiaoling Qiu, Zhiping Wang

  • 1Department of Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, People's Republic of China.

Insights

Quantum dots (QDs) effectively deliver survivin short interfering RNA (siRNA) to oral cancer cells, silencing gene expression. This demonstrates QDs as a promising non-viral vector for gene therapy applications.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Gene silencing using short interfering RNA (siRNA) is a key method for studying gene function in mammalian cells.
  • Oral squamous cell carcinoma (OSCC) presents a significant challenge, necessitating novel therapeutic strategies.
  • Developing efficient and specific non-viral gene delivery vectors is crucial for advancing gene therapy.

Purpose of the Study:

  • To evaluate quantum dots (QDs) as non-viral vectors for delivering survivin siRNA.
  • To assess the efficiency of QDs in downregulating survivin gene expression in Tca8113 OSCC cells.
  • To investigate the cellular uptake and intracellular localization of QD-siRNA complexes.

Main Methods:

  • Preparation of water-dispersible, cationically-modified QDs complexed with anionic survivin siRNA.
  • Monitoring cellular uptake and allocation of QD-siRNA complexes using confocal laser scanning microscopy.
  • Quantifying survivin messenger RNA (mRNA) levels via real-time polymerase chain reaction (PCR) to confirm gene silencing.

Main Results:

  • CdSe QDs exhibited high-intensity fluorescence, enabling visualization within Tca8113 cells.
  • Successful transfection of Tca8113 cells with QD-siRNA complexes was confirmed by dual fluorescence imaging.
  • Real-time PCR demonstrated a significant reduction in survivin mRNA levels, indicating successful gene silencing.

Conclusions:

  • Water-soluble CdSe QDs effectively complex with survivin siRNA, acting as efficient non-viral gene delivery vectors.
  • QD-siRNA complexes show excellent fluorescent properties and successfully downregulate survivin gene expression in OSCC cells.
  • QDs represent a novel and promising platform for non-viral gene delivery in cancer therapy.